Literature DB >> 6879434

Portal hemodynamics, intestinal absorption, and postshunt encephalopathy.

L F Rikkers.   

Abstract

Although total diversion of portal blood flow has been considered to be the main factor leading to encephalopathy following nonselective shunt (NSS), increased intestinal absorption of cerebral toxins secondary to mesenteric venous decompression could also play a role. Conversely, the low frequency of encephalopathy after the distal splenorenal shunt (DSRS) may be due to preservation of both hepatic portal perfusion and mesenteric venous hypertension. Portal hemodynamics, intestinal absorption of D-xylose, ammonia metabolism, and clinical encephalopathy were assessed preoperatively and in the early and late postoperative periods in cirrhotic patients selected for the DSRS (n = 12) and NSS (n = 10). Preoperatively, NSS patients had significantly less hepatopetal portal blood flow (P = 0.03) and lower D-xylose absorption (P = 0.004) than DSRS patients. DSRS resulted in no significant alterations in hepatic portal perfusion, portal pressure, D-xylose absorption, fasting blood ammonia (NH3), or tolerance to an oral dose of ammonium chloride. In contrast, NSS resulted in complete portal diversion and decompression and significant enhancement of D-xylose absorption on both the early (P = 0.02) and late (P = 0.03) postoperative evaluations. Early and late postoperative levels of MH3 were significantly higher in NSS patients. Encephalopathy was more frequent after NSS (80%) than after DSRS (17%, P = 0.003). When all patients were considered, preoperative to early DSRS (17%, P = 0.003). When all patients were considered, preoperative to early postoperative change in NH3 correlated with change in D-xylose absorption (r = 0.52, p = 0.02), and there were significantly more individuals with a greater than 2 gm increase in D-xylose absorption who developed encephalopathy (83%) than patients with no or minimal increase in D-xylose absorption (33%, P = 0.04). The results of this study suggest that altered intestinal absorption may be one of many factors determining postshunt cerebral function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6879434

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Small-diameter prosthetic H-graft portacaval shunt: definitive therapy for variceal bleeding.

Authors:  A S Rosemurgy; F M Serafini; E E Zervos; S E Goode
Journal:  J Gastrointest Surg       Date:  1998 Nov-Dec       Impact factor: 3.452

2.  The mother lode of liver transplantation, with particular reference to our new journal.

Authors:  T E Starzl
Journal:  Liver Transpl Surg       Date:  1998-01

3.  Improved quality of life after distal splenorenal shunt. A prospective comparison with side-to-side portacaval shunt.

Authors:  G Spina; R Santambrogio; E Opocher; F Galeotti; G Cucchiaro; M Strinna; G Pezzuoli
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

4.  Current concepts in portal hypertension.

Authors:  L R Del Guercio; M N Kinkhabwalla; H L Berman
Journal:  Bull N Y Acad Med       Date:  1985-10

5.  Cirrhosis and Bleeding Esophageal Varices: Historic Perspectives.

Authors:  Antonio V Sterpetti; Steven K Kappes
Journal:  J Gastrointest Surg       Date:  2020-06-04       Impact factor: 3.452

Review 6.  Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited.

Authors:  E M Quigley
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

7.  Long-term results of small-diameter proximal splenorenal venous shunt: a retrospective study.

Authors:  Hao Chen; Wei-Ping Yang; Ji-Qi Yan; Qin-Yu Li; Di Ma; Hong-Wei Li
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

8.  Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective, randomized clinical trial.

Authors:  I J Sarfeh; E B Rypins
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

9.  Shunt surgery versus endoscopic sclerotherapy for long-term treatment of variceal bleeding. Early results of a randomized trial.

Authors:  L F Rikkers; D A Burnett; G D Volentine; K N Buchi; R A Cormier
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

Review 10.  Narrow-diameter portacaval shunts for management of variceal bleeding.

Authors:  J C Collins; E B Rypins; I J Sarfeh
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.